Cargando…
Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model
Although biosimilars offer cost savings in Canadian healthcare, uptake is low. We discuss the literature on international experiences with biosimilar adoption in the context of the Diffusion of Innovations model. We highlight potential challenges with biosimilar implementation and gaps in research n...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Longwoods Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075443/ https://www.ncbi.nlm.nih.gov/pubmed/32176608 http://dx.doi.org/10.12927/hcpol.2020.26133 |
_version_ | 1783507042736013312 |
---|---|
author | Khan, Danial Luig, Thea Mosher, Dianne Campbell-Scherer, Denise |
author_facet | Khan, Danial Luig, Thea Mosher, Dianne Campbell-Scherer, Denise |
author_sort | Khan, Danial |
collection | PubMed |
description | Although biosimilars offer cost savings in Canadian healthcare, uptake is low. We discuss the literature on international experiences with biosimilar adoption in the context of the Diffusion of Innovations model. We highlight potential challenges with biosimilar implementation and gaps in research needed to inform implementation efforts. We observe a lack of systematic description of implementation design and evaluation and a paucity of in-depth and engaged research to understand stakeholders' pragmatic considerations and the knowledge, messages and meanings that shape clinician and patient decisions to choose biosimilars. |
format | Online Article Text |
id | pubmed-7075443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Longwoods Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-70754432021-02-01 Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model Khan, Danial Luig, Thea Mosher, Dianne Campbell-Scherer, Denise Healthc Policy Discussion and Debate Although biosimilars offer cost savings in Canadian healthcare, uptake is low. We discuss the literature on international experiences with biosimilar adoption in the context of the Diffusion of Innovations model. We highlight potential challenges with biosimilar implementation and gaps in research needed to inform implementation efforts. We observe a lack of systematic description of implementation design and evaluation and a paucity of in-depth and engaged research to understand stakeholders' pragmatic considerations and the knowledge, messages and meanings that shape clinician and patient decisions to choose biosimilars. Longwoods Publishing 2020-02 /pmc/articles/PMC7075443/ /pubmed/32176608 http://dx.doi.org/10.12927/hcpol.2020.26133 Text en Copyright © 2020 Longwoods Publishing http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 License, which permits rights to copy and redistribute the work for non-commercial purposes only, provided the original work is given proper attribution. |
spellingShingle | Discussion and Debate Khan, Danial Luig, Thea Mosher, Dianne Campbell-Scherer, Denise Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model |
title | Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model |
title_full | Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model |
title_fullStr | Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model |
title_full_unstemmed | Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model |
title_short | Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model |
title_sort | lessons from international experience with biosimilar implementation: an application of the diffusion of innovations model |
topic | Discussion and Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075443/ https://www.ncbi.nlm.nih.gov/pubmed/32176608 http://dx.doi.org/10.12927/hcpol.2020.26133 |
work_keys_str_mv | AT khandanial lessonsfrominternationalexperiencewithbiosimilarimplementationanapplicationofthediffusionofinnovationsmodel AT luigthea lessonsfrominternationalexperiencewithbiosimilarimplementationanapplicationofthediffusionofinnovationsmodel AT mosherdianne lessonsfrominternationalexperiencewithbiosimilarimplementationanapplicationofthediffusionofinnovationsmodel AT campbellschererdenise lessonsfrominternationalexperiencewithbiosimilarimplementationanapplicationofthediffusionofinnovationsmodel |